港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

生物医药B类股

582.929

+26.7754.81%

涨家数：30

跌家数：2

平家数：2

市盈率：- -

高：589.844

开：556.154

低：552.035

收：556.154

数据加载中...

东曜药业-B盘中异动临近午盘快速拉升5.18%报2.030港元

和誉医药匹米替尼国内申报上市，默克超6亿美元引进

A股午评：沪指涨0.11% 足球概念持续走强

德琪医药-B盘中异动股价大涨5.08%

药明巨诺-B盘中异动急速拉升5.00%报2.100港元

【北京：非中选高价药品使用将受监控定期通报不合理大量使用的科室】近日，北京市进一步完善医药集中带量采购执行机制，强化对非中选高价药品的监管，要求医疗机构优先使用集采中选产品，并建立常态化监测机制保障药品和耗材供应。医药集采平台将对同品种中选药品按价格差异进行“标黄”“标红”分级警示。标色仅反映同品种中选药品价格差异程度，与质量无关。“标红”比“标黄”产品有着更严格的临床使用限制。医疗机构需严格监控警示品种使用情况；定期通报不合理大量使用疗效相同的高价非中选药品的科室和医生，依规处理无正当理由开具此类药品的医生。

康方生物(09926)股价上升5.043%，现价港币$91.65

阿斯达克财经

沛嘉医疗-B盘中异动早盘大幅拉升5.10%

东阳光药与唯信计算达成战略合作，共同推进AI小分子药物研发平台建设

全球CRO排名公布！药明系拿下第三

创新药股延续升势博安生物(06955)涨10.10% 机构指创新药出海逻辑稳健

创新药概念延续涨势昂利康3连板

A股创新药板块持续活跃，众生药业、昂利康涨停，联化科技涨超9%，睿智医药、海辰药业、翰宇药业等高开。

《沪深》A股三大指数开市窄幅分化个别创新药概念股续升

阿斯达克财经

汇丰晋信基金李博康: 未来创新药会出现一定分化非医药投资者或可借主动型医药基金参与投资机会

【2025 EHA】亚盛医药核心产品耐立克®和APG-2575等13项进展入选2025年欧洲血液学协会年会

长城基金梁福睿：“三周期共振”把握创新药投资机遇，看好板块长期价值

创新药再度领涨

每日经济新闻

四环医药：跨越制药边界成就美与创新

科望医药无商业化三年亏17亿：创始人年薪千万，负债率超500%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1574/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":582.92883,"timestamp":1749715694036,"preClose":556.15393,"halted":0,"volume":357396500,"delay":0,"changeRate":0.048143,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":26.774902,"latestTime":"06-12 16:00:00","open":556.15393,"high":589.8439,"low":552.03485,"amount":6650465011,"amplitude":0.067983,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1749778200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749691800000,1749700800000],[1749704400000,1749715200000]],"pbRate":4.544795,"peRate":-27.989646,"turnoverRate":0.013455,"increases":30,"decrements":3,"flats":0,"marketCap":341246284608,"floatMarketCap":311991366208},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":589.8439,"amplitude":0.067983,"preClose":556.15393,"low":552.03485,"pbRate":"4.544795","latestPrice":582.92883,"volume":357396500,"delay":0,"open":556.15393,"prevYearClose":331.1933,"prevWeekClose":504.495,"prevMonthClose":491.683,"prevQuarterClose":455.082,"fiveDayClose":499.991,"twentyDayClose":449.278,"sixtyDayClose":416.248,"secType":"PLATE","market":"HK","turnoverRate":0.013455,"peRate":-27.989646,"marketCap":341246284608,"floatMarketCap":311991366208,"timestamp":1749715694036,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":30,"down":2,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542365726","title":"东曜药业-B盘中异动 临近午盘快速拉升5.18%报2.030港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542365726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542365726?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 11:47","pubTimestamp":1749527248,"startTime":"0","endTime":"0","summary":"2025年06月10日临近午盘11时47分，东曜药业-B股票出现异动，股价快速拉升5.18%。截至发稿，该股报2.030港元/股，成交量8.44万股，换手率0.01%，振幅5.18%。资金方面，该股资金流入16.8652万港元，流出772港元。东曜药业-B股票所在的生物技术行业中，整体涨幅为2.19%。其相关个股中，晶泰控股、映恩生物-B、博安生物涨幅较大，振幅较大的相关个股有帝王国际投资、晶泰控股、中国抗体-B，振幅分别为18.60%、18.47%、16.28%。该公司主要在中国国内市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610114728a70183c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610114728a70183c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01875"],"gpt_icon":0},{"id":"2542729365","title":"和誉医药匹米替尼国内申报上市，默克超6亿美元引进","url":"https://stock-news.laohu8.com/highlight/detail?id=2542729365","media":"时代财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542729365?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 11:46","pubTimestamp":1749527196,"startTime":"0","endTime":"0","summary":"2023年12月，默克与和誉医药签署协议，默克最初获得匹米替尼在中国内地、中国香港、中国澳门及中国台湾所有适应症进行商业化的独家授权，并拥有全球商业化权利的独家选择权。今年5月29日，和誉医药宣布，已收到默克根据双方签订的授权协议支付的行使匹米替尼全球商业化选择权行权费8500万美元，该选择权行权费将确认为2025年度公司实现的营收。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506101148109778d299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506101148109778d299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","BK1161","LU2488822045.USD","02256","BK1574"],"gpt_icon":0},{"id":"2542636300","title":"A股午评：沪指涨0.11% 足球概念持续走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2542636300","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542636300?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 11:37","pubTimestamp":1749526644,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0254","BK0210","002940","BK0028","BK4539","002181","605099","BK0012","BK1161","BK0115","399300","603023","688685","301287","LU1878469433.USD","399006","300875","002317","002900","BK0188","BK0214","BK4108","688288","159992","BK4535","BK0077","BK0251","EDR","BK0239","BK0201","BK0279","BK4551","06978","399001","159982","161024","BK1574","BK0046","BK0098","300485"],"gpt_icon":0},{"id":"2542363964","title":"德琪医药-B盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542363964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542363964?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 11:06","pubTimestamp":1749524785,"startTime":"0","endTime":"0","summary":"2025年06月10日早盘11时06分，德琪医药-B股票出现波动，股价急速上涨5.08%。截至发稿，该股报4.140港元/股，成交量327.8万股，换手率0.48%，振幅5.33%。德琪医药-B股票所在的药品行业中，整体涨幅为0.68%。其相关个股中，三生制药、绿叶制药、石药集团涨幅较大，振幅较大的相关个股有三生制药、海王英特龙、石药集团，振幅分别为14.42%、10.58%、9.52%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610110625a70177a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610110625a70177a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1191","06996"],"gpt_icon":0},{"id":"2542245368","title":"药明巨诺-B盘中异动 急速拉升5.00%报2.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542245368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542245368?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 10:59","pubTimestamp":1749524394,"startTime":"0","endTime":"0","summary":"2025年06月10日早盘10时59分，药明巨诺-B股票出现波动，股价急速上涨5.00%。截至发稿，该股报2.100港元/股，成交量181.722万股，换手率0.44%，振幅6.50%。资金方面，该股资金流入247.296万港元，流出90.5835万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。药明巨诺-B股票所在的生物技术行业中，整体涨幅为0.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610105954a4a1414e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610105954a4a1414e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2542368433","title":"【北京：非中选高价药品使用将受监控 定期通报不合理大量使用的科室】近日，北京市进一步完善医药集中带量采购执行机制，强化对非中选高价药品的监管，要求医疗机构优先使用集采中选产品，并建立常态化监测机制保障药品和耗材供应。医药集采平台将对同品种中选药品按价格差异进行“标黄”“标红”分级警示。标色仅反映同品种中选药品价格差异程度，与质量无关。“标红”比“标黄”产品有着更严格的临床使用限制。医疗机构需严格监控警示品种使用情况；定期通报不合理大量使用疗效相同的高价非中选药品的科室和医生，依规处理无正当理由开具此类药品的医生。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542368433","media":"金融界","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542368433?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 10:55","pubTimestamp":1749524156,"startTime":"0","endTime":"0","summary":"近日，北京市进一步完善医药集中带量采购执行机制，强化对非中选高价药品的监管，要求医疗机构优先使用集采中选产品，并建立常态化监测机制保障药品和耗材供应。医药集采平台将对同品种中选药品按价格差异进行“标黄”“标红”分级警示。标色仅反映同品种中选药品价格差异程度，与质量无关。“标红”比“标黄”产品有着更严格的临床使用限制。医疗机构需严格监控警示品种使用情况；定期通报不合理大量使用疗效相同的高价非中选药品的科室和医生，依规处理无正当理由开具此类药品的医生。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/10105550965524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","09939","159938","BK1574","BK1161"],"gpt_icon":0},{"id":"2542635983","title":"康方生物(09926)股价上升5.043%，现价港币$91.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2542635983","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542635983?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 10:55","pubTimestamp":1749524100,"startTime":"0","endTime":"0","summary":"[上升股]康方生物(09926) 股价在上午10:55比前收市价上升5.043%，现股价为港币$91.65。至目前为止，今日最高价为$91.65，而最低价为$86.95。总成交量为742.562万股，总成交金额为港币$6.643亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR250610799/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00BPRC5H50.USD","LU0348783233.USD","LU2488822045.USD","LU1794554557.SGD","IE00B543WZ88.USD","BK1574","LU0417516571.SGD","09926","LU1720050803.USD","BK1161","LU0348784397.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2542636539","title":"沛嘉医疗-B盘中异动 早盘大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542636539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542636539?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 10:49","pubTimestamp":1749523757,"startTime":"0","endTime":"0","summary":"2025年06月10日早盘10时49分，沛嘉医疗-B股票出现波动，股价大幅拉升5.10%。沛嘉医疗-B股票所在的医疗设备及用品行业中，整体涨幅为0.13%。其相关个股中，巨星医疗控股、百心安-B、心通医疗-B涨幅较大，振幅较大的相关个股有百心安-B、心通医疗-B、启明医疗-B，振幅分别为22.36%、13.98%、9.47%。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610104917a7017276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610104917a7017276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","09996","BK1583"],"gpt_icon":0},{"id":"2542336864","title":"东阳光药与唯信计算达成战略合作，共同推进AI小分子药物研发平台建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2542336864","media":"蓝鲸财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542336864?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 10:36","pubTimestamp":1749522967,"startTime":"0","endTime":"0","summary":"东阳光药&唯信计算近日，广东东阳光药业股份有限公司与唯信计算达成战略合作，双方将围绕东阳光药HEC药物智能发现平台的建设与完善展开深度协同。基于此次合作，东阳光药将携手唯信计算，丰富智能化、高通量的HEC药物智能发现平台的研发生态系统，共同推动创新药研发全流程的数字化升级，从而突破传统研发效率瓶颈，缩短创新药临床前开发周期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1749522790293443174","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["06978","BK1574","BK1161"],"gpt_icon":0},{"id":"2542235071","title":"全球CRO排名公布！药明系拿下第三","url":"https://stock-news.laohu8.com/highlight/detail?id=2542235071","media":"同壁财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542235071?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 10:27","pubTimestamp":1749522453,"startTime":"0","endTime":"0","summary":"据医药魔方数据，在全球CRO企业中，药明系（合并药明康德、药明生物、药明合联）2024年收入87.01亿美元，位列第3；第1、第2名分别为IQVIA（艾昆纬）、Thermo（赛默飞）。药明系凭借大而全的业务布局，占据榜单前列。展望后市，借鉴全球CRO巨头的发展经验，中国CRO行业或能更好地融入全球生物医药产业链。恒生医药ETF（159892）聚焦创新药产业链上中下游，持仓药明康德、药明生物、药明合联等标的，在港交所18A制度优势下同时覆盖众多创新药标的，有望持续受益于本轮创新药热度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610103453a4a13896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610103453a4a13896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02359","603259","02269","02268","BK1141","BK1574","06978","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2542060352","title":"创新药股延续升势 博安生物(06955)涨10.10% 机构指创新药出海逻辑稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=2542060352","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542060352?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 09:48","pubTimestamp":1749520130,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药股延续升势，博安生物 涨10.10%，绿叶制药涨4.70%，药明生物涨4.04%，康方生物涨3.61%，和黄医药涨3.14%，三生制药涨3.20%，翰森制药涨2.87%，石药集团涨3.06%。消息面上，国泰海通发研报指，近期BD催化不断，创新药出海逻辑稳健，行情有望持续。近期频繁落地的BD验证了跨国药企对中国优质创新药资产的需求远大于对地缘风险的担忧，创新药出海逻辑稳健，有望继续催化创新药行情。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"47d9c11e17c5559513797f3d830cf623","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1960165","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00013","03692","BK1593","LU1226287875.USD","LU0417516902.SGD","LU2488822045.USD","LU0823426480.USD","IE00B543WZ88.USD","LU0572944931.SGD","LU1993786604.SGD","BK1587","LU1242518931.SGD","LU1720050803.USD","01530","IE00BPRC5H50.USD","BK1576","IE00B5MMRT66.SGD","IE00B0JY6N72.USD","LU0819121731.USD","LU0327786744.USD","06978","BK1588","LU1807302812.USD","LU1688375341.USD","LU1226287792.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","02186","IE00BZ08YR35.GBP","BK1191","09926","159992","LU0880133367.SGD","IE00BZ08YS42.EUR","LU1152091168.USD","LU1152091754.HKD","02269","LU0140636845.USD","LU0417516738.SGD","BK1574","LU1960683339.HKD","LU0516423091.SGD","IE00B031HY20.USD","SG9999004220.SGD","SG9999002463.SGD","LU0708995583.HKD","IE0008368742.USD","06955","LU0072913022.USD"],"gpt_icon":1},{"id":"2542357024","title":"创新药概念延续涨势 昂利康3连板","url":"https://stock-news.laohu8.com/highlight/detail?id=2542357024","media":"上海","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542357024?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 09:38","pubTimestamp":1749519480,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯 6月10日，创新药概念延续涨势，截至9时34分，昂利康3连板，众生药业2连板，哈三联涨停，睿智医药涨超12%，万邦医药、北陆药业等涨超5%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"47d9c11e17c5559513797f3d830cf623","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-06-10/doc-inezpywk5845868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","159992","BK1574","002940","BK0239","06978"],"gpt_icon":0},{"id":"2542354471","title":"A股创新药板块持续活跃，众生药业、昂利康涨停，联化科技涨超9%，睿智医药、海辰药业、翰宇药业等高开。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542354471","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542354471?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 09:30","pubTimestamp":1749519008,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"47d9c11e17c5559513797f3d830cf623","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0188","399300","BK0118","BK1574","002317","BK0239","06978","BK1161","002250","002940","159982","BK0229","300149","BK0070","159992","300199","BK0028","300584","BK0077","BK0216"],"gpt_icon":0},{"id":"2542354248","title":"《沪深》A股三大指数开市窄幅分化  个别创新药概念股续升","url":"https://stock-news.laohu8.com/highlight/detail?id=2542354248","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542354248?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 09:29","pubTimestamp":1749518940,"startTime":"0","endTime":"0","summary":"据《央视》报道，中美经贸磋商机制首次会议今日 继续进行。人民银行今日公开市场开展1,986亿元人民币(下同)七天期逆回购操作，操作利率持平于1.4%。今日有4,545亿元逆回购到期，单日净回笼2,559亿元。人民币兑美元中间价报7.1840，上调15点。A股三大指数开市个别发展。上证指数开盘报3,402点，高开2点或0.07%。深证成指开盘报10,248点，低开1点或0.02%。个别创新药概念股上升，海辰药业及千红制药分别高开约4.1%及4.2%。(A股报价延迟最少十五分钟。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180419151914120_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180419151914120_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1445646&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159982","BK1574","06978","159992","399300","BK1161"],"gpt_icon":0},{"id":"2542105354","title":"汇丰晋信基金李博康: 未来创新药会出现一定分化 非医药投资者或可借主动型医药基金参与投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2542105354","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542105354?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 09:18","pubTimestamp":1749518280,"startTime":"0","endTime":"0","summary":"　　他指出，当前时点，创新药的涨幅确实比较可观，我们认为伴随ASCO大会的圆满落幕，短期可期待的行业性的剧烈情绪催化相对有限，接下来可能会出现一定的分化。由于医药板块内部细分行业较多，且行业之间差异较大，因此从投资上来看，我们认为对于非医药专业的投资者，选择主动型医药基金或许能够更好地参与医药板块的投资机会。另外，由于创新药的定价并非针对于当期业绩，股价波动相对较大，但产业大趋势非常明确。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjsy/2025-06-10/doc-inezpyws9160446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["160635","BK1574","BK4521","BK4588","BK4207","BK1161","HSBC","LU0310800965.SGD","09939","LU1267930227.SGD","LU2236285917.USD","BK1515","159938","159992","06978","LU0128525689.USD","LU0052756011.USD","BK4585"],"gpt_icon":0},{"id":"2542366048","title":"【2025 EHA】亚盛医药核心产品耐立克®和APG-2575等13项进展入选2025年欧洲血液学协会年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2542366048","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542366048?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 09:17","pubTimestamp":1749518220,"startTime":"0","endTime":"0","summary":"美国马里兰州罗克维尔市和中国苏州 2025年6月10日 /美通社/ -- 致力于在肿瘤等领域开发创新药物的领先的生物医药企业——亚盛医药宣布，涉及公司原创1类新药奥雷巴替尼、Bcl-2抑制剂APG-2575、EED抑制剂APG-5918等重磅品种的13项研究进展将在2025年6月12日至15日于意大利米兰举行的2025年欧洲血液学协会年会上公布，其中包括1项口头报告，及多项壁报展示和线上发表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4706661_ZH06661_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1161","BK4129","LU1923622291.USD","BK1574","LU2125909916.SGD","AAPG","06855","APG","LU2125909759.SGD","BK4139"],"gpt_icon":0},{"id":"2542354124","title":"长城基金梁福睿：“三周期共振”把握创新药投资机遇，看好板块长期价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2542354124","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542354124?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 09:15","pubTimestamp":1749518100,"startTime":"0","endTime":"0","summary":"近期，创新药板块持续走强，引发市场广泛关注。Wind数据显示，截至6月5日，自年初低位以来，万得创新药指数已上涨超过31%，明显跑赢大盘。　　市场普遍预计，今年创新药将持续是医药板块的主线。　　为了挖掘到这样的优质标的，梁福睿形成了一套独特的“三周期共振”投资策略，即寻找产业周期、公司成长周期和资本市场周期共振的公司。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2025-06-10/doc-inezpywn3674529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","BK1161","BK1574","159992"],"gpt_icon":0},{"id":"2542735198","title":"创新药再度领涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2542735198","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542735198?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 08:51","pubTimestamp":1749516713,"startTime":"0","endTime":"0","summary":"信达生物、迪哲医药、科伦博泰、泽璟制药、中国生物制药等公司的优质创新药品种发布数据。从今年的AACR和ASCO两项会议可以看出，中国创新药在新靶点、新技术、新疾病领域的布局已呈现领先趋势。中国创新药具备高效率、低成本的开发优势，当前在热门技术赛道如ADC、双抗、细胞治疗等已经具备竞争优势，有望持续展现行业竞争力。此外，国际化方面，中国创新药“出海”进程显著提速。展望未来，创新药有望迎来价值重估。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061008540897789577&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061008540897789577&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","IE00BZ08YR35.GBP","BK1161","IE00BZ08YT58.USD","09995","06978","BK1191","BK1521","01801","BK1589","01530","01177","BK1515","IE00BZ08YS42.EUR","688331"],"gpt_icon":0},{"id":"2542516213","title":"四环医药：跨越制药边界 成就美与创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2542516213","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542516213?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 08:36","pubTimestamp":1749515761,"startTime":"0","endTime":"0","summary":"以制药企业的严谨与创新，打造中国领先医美及生物制药企业。四环医药坚持“医美+创新药”的双轮驱动战略，成功实现转型升级。旗下子公司轩竹生物储备多款在研创新药产品，后续上市有望贡献业绩增量，可持续关注商业化兑现进度。我们选取医美、仿制药和创新药赛道的代表性公司作为估值参考，首次覆盖给予“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610083604a7014682&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610083604a7014682&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","BK1600","BK1191","01477","BK1593","BK1515","BK1574"],"gpt_icon":0},{"id":"2542176354","title":"科望医药无商业化三年亏17亿：创始人年薪千万，负债率超500%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542176354","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542176354?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 08:21","pubTimestamp":1749514860,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　日前，科望医药集团二度递表港交所。2024年6月公司首次向港交所递交上市申请，但因未在6个月内通过聆讯，申请失效。　　然而，公司目前尚无批准商业销售的产品，2022年至2024年三年合计亏损17.12亿元。截至2024年末，公司可转换可赎回优先股的账面价值超32亿元，负债净额超27亿元，现金流出现较大下滑态势，引发市场关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/stockzmt/2025-06-10/doc-inezpyws9146010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","159938","BK1515","BK1161","09939"],"gpt_icon":0}],"pageSize":20,"totalPage":34,"pageCount":8,"totalSize":676,"code":"91000000","status":"200"}]}}